Targeting specific proteins to improve treatment for glioblastoma
Generating Synthetic Lethality in Glioblastoma with a First-In-Class Non-Muscle Myosin II Inhibitor
['FUNDING_R01'] · MAYO CLINIC JACKSONVILLE · NIH-11016213
This study is looking at a new drug that might help people with glioblastoma, a type of brain cancer, by working alongside current treatments like radiation to make them more effective and hopefully improve survival rates.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MAYO CLINIC JACKSONVILLE (nih funded) |
| Locations | 1 site (JACKSONVILLE, UNITED STATES) |
| Trial ID | NIH-11016213 on ClinicalTrials.gov |
What this research studies
This research investigates a new treatment approach for glioblastoma, a type of brain cancer, by using a novel drug that inhibits certain proteins involved in cancer cell movement and survival. The study aims to understand how this drug, combined with existing therapies, can enhance the effectiveness of treatments like radiation and other targeted therapies. By exploring the interactions between this drug and cancer signaling pathways, the researchers hope to improve patient outcomes and extend survival rates. The ultimate goal is to prepare for clinical trials that will test this treatment in humans.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who are seeking new treatment options.
Not a fit: Patients with other types of brain tumors or those who are not diagnosed with glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients with glioblastoma, potentially improving survival rates and quality of life.
How similar studies have performed: Previous research has shown promising results with similar approaches targeting cancer cell signaling and movement, indicating potential for success in this novel treatment.
Where this research is happening
JACKSONVILLE, UNITED STATES
- MAYO CLINIC JACKSONVILLE — JACKSONVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROSENFELD, STEVEN S — MAYO CLINIC JACKSONVILLE
- Study coordinator: ROSENFELD, STEVEN S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.